Optomed Plc Stock Exchange Release 20 March 2020 at 15.00,
Helsinki
Optomed Annual Report 2019 published
Optomed's Annual Report 2019 has been published. The Annual Report includes the
company's consolidated and parent company financial statements, the report of
the board of directors, corporate governance statement and remuneration report
for governing bodies.
The Annual Report is attached to this release as a PDF file and it is available
in English and Finnish on the corporate website
https://www.optomed.com/investors/annual-report-2019/.
Optomed Plc
Further enquiries
Lars Lindqvist, CFO, Optomed Plc, lars.lindqvist@optomed.com
Sakari Knuutti, CLO, Optomed Plc, sakari.knuutti@optomed.com
Optomed in Brief
Optomed is a Finnish medical technology company and a leading providers of
handheld fundus cameras. Optomed combines handheld cameras with software and
artificial intelligence with the aim to transform the diagnostic process of
blinding eye-diseases such as rapidly increasing diabetic retinopathy. In its
business Optomed focuses on eye-screening devices and software solutions related
R&D in Finland and sales through different channels in over 60 countries. The
company has an extensive portfolio of 55 international patents protecting the
technology. In 2019, Optomed’s revenue reached EUR 15 million and 2018 pro forma
revenue amounted to EUR 14.5 million. At the end of 2019, Optomed employed 108
professionals.